![](https://crownheights.info/assets/2021/12/IV-Drip-768x512.jpg?v=1640572643)
U.S. Pauses Allocation of Regeneron, Lilly COVID-19 Antibodies
The U.S. government has paused the distribution of COVID-19 antibody treatments from Regeneron Pharmaceuticals (REGN.O) and Eli Lilly (LLY.N), saying the therapies were unlikely to be effective against the Omicron coronavirus variant.